Singla Akshita, Saraswat Rajkumar K, Bharadwaj Avnish, Singh Sapna
Anaesthesiology, Mahatma Gandhi Medical College and Research Institute, Jaipur, IND.
Cureus. 2024 Feb 23;16(2):e54768. doi: 10.7759/cureus.54768. eCollection 2024 Feb.
Introduction Intravenous dexmedetomidine is known to cause major adverse effects such as bradycardia, hypotension, cardiac arrhythmias, and heart block when used as premedication for attenuation of the laryngoscopy and intubation response, limiting its routine use. Thus, it is important to study other routes of administration of dexmedetomidine. Objectives To compare the hemodynamic response and sedation score between intravenous and nebulized dexmedetomidine as premedication for the attenuation of the laryngoscopy and intubation response. Materials and methods In this study, 60 patients fulfilling inclusion criteria undergoing surgeries under general anesthesia (ASA Grade I and II) were randomly allocated into two groups of 30 patients each. Group IV received intravenous 1 mcg/kg dexmedetomidine in 100 mL normal saline, and Group IN received nebulization with 1 mcg/kg dexmedetomidine diluted to a total volume of 5 cc of normal saline, 30 minutes prior to the induction of general anesthesia. Sedation scores were calculated using the Ramsay sedation score at 20 minutes after the administration of the drug; patients were induced by the standard protocol, and laryngoscopy was performed. Vitals were recorded before the administration of the drug and after intubation at stipulated time intervals. Results The median heart rate becomes significantly lower at 15 minutes (70 vs. 76.5) and 20 minutes (66 vs. 76) after induction among Group IV as compared to Group IN. The median systolic blood pressure was significantly lower at 20 minutes in Group IV (110 mmHg) than in Group IN (119 mmHg). The median diastolic blood pressure was significantly lower at 10 minutes (76 vs. 79), 15 minutes (70 vs. 77), and 20 minutes (69 vs. 78.5) in Group IV than in Group IN. The median of mean arterial pressure was significantly lower at 15 minutes (84.8 vs. 91.5) and 20 minutes (83 vs. 92) in Group IV than in Group IN. A comparison of vitals after induction shows that the median heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure were significantly lower statistically among Group IV as compared to Group IN at 0, 1, 3, 5, 10, 15, and 30 minutes after induction (except for systolic blood pressure at 3 minutes). The median sedation score was lower in Group IN (0) than in Group IV (1); this difference is statistically significant. Conclusion The obtundation of hemodynamic responses following laryngoscopy and maintaining hemodynamics intraoperatively is statistically better with nebulized dexmedetomidine compared to intravenous dexmedetomidine.
引言 已知静脉注射右美托咪定在用作减轻喉镜检查和插管反应的术前用药时会引起诸如心动过缓、低血压、心律失常和心脏传导阻滞等主要不良反应,这限制了其常规使用。因此,研究右美托咪定的其他给药途径很重要。
目的 比较静脉注射和雾化吸入右美托咪定作为减轻喉镜检查和插管反应的术前用药时的血流动力学反应和镇静评分。
材料和方法 在本研究中,60例符合纳入标准且接受全身麻醉(ASA I级和II级)手术的患者被随机分为两组,每组30例。IV组在全身麻醉诱导前30分钟静脉注射1 μg/kg右美托咪定溶于100 mL生理盐水中,IN组用1 μg/kg右美托咪定稀释至总体积5 cc生理盐水中进行雾化吸入。给药20分钟后使用Ramsay镇静评分计算镇静评分;患者按标准方案诱导,并进行喉镜检查。在给药前和插管后按规定时间间隔记录生命体征。
结果 与IN组相比,IV组诱导后15分钟(70对76.5)和20分钟(66对76)时的心率中位数显著更低。IV组20分钟时的收缩压中位数(110 mmHg)显著低于IN组(119 mmHg)。IV组在10分钟(76对79)、15分钟(70对77)和20分钟(69对78.5)时的舒张压中位数显著低于IN组。IV组在15分钟(84.8对91.5)和20分钟(83对92)时的平均动脉压中位数显著低于IN组。诱导后生命体征比较显示,诱导后0、1、3、5、10、15和30分钟时,IV组的心率、收缩压、舒张压和平均动脉压中位数在统计学上显著低于IN组(诱导后3分钟时的收缩压除外)。IN组的镇静评分中位数(0)低于IV组(1);这种差异具有统计学意义。
结论 与静脉注射右美托咪定相比,雾化吸入右美托咪定在喉镜检查后对血流动力学反应的抑制以及术中维持血流动力学方面在统计学上表现更好。